ESC Professional Premium Access

Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.

Congress Presentation

About the speaker

Doctor Sanghyup Lee

Yonsei University, Seoul (Korea (Republic of))
0 follower

8 more presentations in this session

Associations between DAPT score and long-term mortality post PCI

Speaker: Doctor M. Tan (Melbourne, AU)


Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk

Speaker: Doctor S. Lahu (Munich, DE)


Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials

Speaker: Doctor S. Alexiou (Thessaloniki, GR)


Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trials

Speaker: Doctor F. Costa (Messina, IT)


Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

Speaker: Doctor S. Delgado (Taguig City, PH)


Access the full session

Antithrombotic and anticoagulant therapy

Speakers: Doctor S. Lee, Doctor M. Tan, Doctor S. Lahu, Doctor S. Alexiou, Doctor F. Costa...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk